Bethesda-based biotech firm Northwest Biotherapeutics raises $12.6 million in latest offering - Baltimore Business Journal

Bethesda-based Northwest Biotherapeutics Inc. is raising $12.6 million in new funding as part of a direct offering to health care-focused investors, according to a company announcement.